Hello, folks, and how are you today? If the answer is very, very busy, well, we are not surprised. The aftermath of the hurricane continues to affect our water-logged region, which is preparing for yet another storm, and it is Election Day, as you know, on this side of the pond. And this reminds us: whatever your persuasion, we urge you to vote. It is an opportunity not to be missed. Meanwhile, we have gathered a few interesting items for you to get started. Hope your day goes well and let us know if you hear anything interesting...
FDA Staff Highlights Heart Risk With Novo Insulin (Reuters)
Novo Nordisk May Pull Insulin From Hungary Over Price Row (Nepszabadsag)
Takeda To Pay $140M For Envoy Therapeutics (Pharma Times)
Amgen Drug Lowers Cholesterol For The 'Statin Intolerant' (Bloomberg News)
India Creates Surveillance Teams To Catch Effluent Dumping (PharmaBiz)
Abbott's AbbVie Spinoff Completes Record $14.7B Debt Sale (Reuters)
Roche's Good Cholesterol Pill Shows Negative Side Effects (Bloomberg News)
Teva Americas CEO To Retire (Dow Jones)
Sarepta Rare Drug Gets Push From Patient Groups (TheStreet)
EDITOR'S NOTE: Please check this post for updates
2 Comments
Glad you are up and running - and WARM! Given the Tech 'gurus' you have suporting you, I admire your persistence .... they did however 'make the news today?'
http://www.gocomics.com/ziggy/2012/11/06
... or not?
http://frontpagemag.com/2012/matthew-vadum/obamas-army-of-illegal-election-workers/
Yeah, I know it's not directly Pharma related but, you did ask.
"let us know if you hear anything interesting…"
Right up there with the Texas AG warning the UN 'Observers' that they may be subject to arrest if they get within 100 feet of a polling place in Texas.
God Bless Greg Abbot!